Hospital de Clinicas de Passo Fundo

Passo Fundo, Rio Grande do Sul 99010-260

0 studies enrolling now · 3 studies all time

What they study most

Autologous Stem Cell Transplant, Extensive-Stage Small-Cell Lung Cancer, Metastatic or Unresectable Cutaneous Melanoma, Multiple Myeloma, Small-Cell Lung Cancer

Studies at this site

• Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab — Running, not enrolling
• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed